Table 2 Overall in-hospital mortality. Data are collected for the last available observation when time of follow up is specified
Overall mortality | REBOA | Control | Time/setting | OR adjusted/matched | Description of adjustment | ||||
|---|---|---|---|---|---|---|---|---|---|
N | Tot | % | n | Tot | % | ||||
Aso 2017 [22] (REBOA vs RT) | 90 | 191 | 47 | 48 | 68 | 70.6 | Time frame not reported | Hazard ratio = 0.94; 95%CI = 0.60–1.48§ OR 0.821; 95% CI 0.306–1.234 | Adjusted propensity score |
Brenner 2018 [23] (REBOA vs RT) | 75 | 83 | 90.3 | 197 | 202 | 97.5 | 24 h | OR = 0.24; 95% CI 0.08–0.75 | None |
Abe 2016 [21] (REBOA vs RT) | 405 | 636 | 63.7 | 210 | 267 | 78.7 | Time frame not reported ED | OR 0.261 95%CI 0.130–0.523 Pair-matched n = 304 | Adjusted propensity score |
DuBose 2016 [24] (REBOA vs RT) | 33 | 46 | 71.7 | 57 | 68 | 83.8 | ED 24 h | OR = 0.263; 95% CI = 0.043–1.609 | not reported (regression) |
Moore 2015 [29] (REBOA vs RT) | 15 | 24 | 62.5 | 65 | 72 | 90.3 | time frame not reported ED | None | None |
Matsumara 2017 (REBOA vs REBOA+RT) | 41 | 76 | 53.9 | 27 | 30 | 90.0 | 24 h 1 month At discharge | None | None |
Nori 2015* [31] (REBOA vs no-REBOA) | 259 | 351 | 73.8 | 709 | 1456 | 48.7 | Time frame not reported | OR = 2.97; 95% CI = 2.29–3.84 Pairs matched 1:5 | Adjusted propensity score |
GarcÃa 2020 [25] (REBOA vs no-REBOA) | 5 | 28 | 17.8 | 48 | 317 | 15.1 | Time frame not reported | OR = 0.20; 95%CI 0.05–0.77 | Adjusted propensity score |
Inoue 2016* [26] (REBOA vs no-REBOA) | 386 | 625 | 61.7 | 283 | 625 | 45.3 | Time frame not reported ED | OR = 1.95, 95% CI 1.56–2.45 | Adjusted propensity score ° |
Joseph 2019* [27] (REBOA vs no-REBOA) | 50 | 140 | 35.7 | 53 | 280 | 18.9 | ED overall | OR= 2.38; 95% CI= 1.51–3.76 | Adjusted propensity score |
Yamamoto 2019* [30] (REBOA vs no-REBOA) | 64 | 117 | 54.7 | 79 | 117 | 67.5 | Time frame not reported | OR = 0.58; 95% CI = 0.34–0.99 | Adjusted propensity score |